0001209191-22-015590.txt : 20220303
0001209191-22-015590.hdr.sgml : 20220303
20220303170108
ACCESSION NUMBER: 0001209191-22-015590
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOLGER JOHN C
CENTRAL INDEX KEY: 0001183863
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37894
FILM NUMBER: 22710019
MAIL ADDRESS:
STREET 1: 4978 SANTA ANITA AVENUE
STREET 2: SUITE 205
CITY: TEMPLE CITY
STATE: CA
ZIP: 91780
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulgent Genetics, Inc.
CENTRAL INDEX KEY: 0001674930
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 812621304
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205
CITY: TEMPLE CITY
STATE: CA
ZIP: 91780
BUSINESS PHONE: 626-350-0537
MAIL ADDRESS:
STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205
CITY: TEMPLE CITY
STATE: CA
ZIP: 91780
FORMER COMPANY:
FORMER CONFORMED NAME: Fulgent Diagnostics, Inc.
DATE OF NAME CHANGE: 20160517
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-01
0
0001674930
Fulgent Genetics, Inc.
FLGT
0001183863
BOLGER JOHN C
C/O FULGENT GENETICS, INC.
4978 SANTA ANITA AVE.
TEMPLE CITY
CA
91780
1
0
0
0
Common Stock
2022-03-01
4
M
0
625
3.925
A
2625
D
Common Stock
2022-03-01
4
S
0
625
61.4202
D
2000
D
Common Stock
2022-03-01
4
M
0
625
5.8098
A
2625
D
Common Stock
2022-03-01
4
S
0
625
61.402
D
2000
D
Common Stock
2022-03-01
4
M
0
625
15.82
A
2625
D
Common Stock
2022-03-01
4
S
0
625
61.2681
D
2000
D
Stock Option (Right to Buy)
3.925
2022-03-01
4
M
0
625
0.00
D
2028-05-18
Common Stock
625
313
D
Stock Option (Right to Buy)
5.8098
2022-03-01
4
M
0
625
0.00
D
2029-05-30
Common Stock
625
1563
D
Stock Option (Right to Buy)
15.82
2022-03-01
4
M
0
625
0.00
D
2030-05-26
Common Stock
625
2813
D
The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
/s/ Paul Kim, as Attorney-in-fact
2022-03-03